Asymmetric Unit(hide GO term definitions)
Chain A,C ( PSD10_MOUSE | Q9Z2X2)
| molecular function |
|---|
| | GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| biological process |
|---|
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0007253 | | cytoplasmic sequestering of NF-kappaB | | The selective interaction of the transcription factor NF-kappaB with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus. |
| | GO:0043518 | | negative regulation of DNA damage response, signal transduction by p53 class mediator | | Any process that stops, prevents, or reduces the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage. |
| | GO:0043409 | | negative regulation of MAPK cascade | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the MAPKKK cascade. |
| | GO:0032088 | | negative regulation of NF-kappaB transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| | GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| | GO:0090201 | | negative regulation of release of cytochrome c from mitochondria | | Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
| | GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0030307 | | positive regulation of cell growth | | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| | GO:0045737 | | positive regulation of cyclin-dependent protein serine/threonine kinase activity | | Any process that activates or increases the frequency, rate or extent of CDK activity. |
| | GO:0032436 | | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| | GO:0031398 | | positive regulation of protein ubiquitination | | Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| | GO:0070682 | | proteasome regulatory particle assembly | | The aggregation, arrangement and bonding together of a mature, active proteasome regulatory particle complex. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0045111 | | intermediate filament cytoskeleton | | Cytoskeletal structure made from intermediate filaments, typically organized in the cytosol as an extended system that stretches from the nuclear envelope to the plasma membrane. Some intermediate filaments run parallel to the cell surface, while others traverse the cytosol; together they form an internal framework that helps support the shape and resilience of the cell. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0000502 | | proteasome complex | | A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core. |
| | GO:0008540 | | proteasome regulatory particle, base subcomplex | | The subcomplex of the proteasome regulatory particle that directly associates with the proteasome core complex. |
Chain B,D ( PRS6B_RAT | Q63570)
| molecular function |
|---|
| | GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| | GO:0016887 | | ATPase activity | | Catalysis of the reaction: ATP + H2O = ADP + phosphate + 2 H+. May or may not be coupled to another reaction. |
| | GO:0017025 | | TBP-class protein binding | | Interacting selectively and non-covalently with a member of the class of TATA-binding proteins (TBP), including any of the TBP-related factors (TRFs). |
| | GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| | GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| | GO:0036402 | | proteasome-activating ATPase activity | | Catalysis of the reaction: ATP + H2O = ADP + phosphate, which promotes unfolding of protein substrates, and channel opening of the core proteasome. |
| biological process |
|---|
| | GO:0001824 | | blastocyst development | | The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm. |
| | GO:0045899 | | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | | Any process that activates or increases the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly. |
| | GO:1901800 | | positive regulation of proteasomal protein catabolic process | | Any process that activates or increases the frequency, rate or extent of proteasomal protein catabolic process. |
| | GO:0030163 | | protein catabolic process | | The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:0030433 | | ubiquitin-dependent ERAD pathway | | The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0031597 | | cytosolic proteasome complex | | A proteasome complex found in the cytosol of a cell. |
| | GO:0016234 | | inclusion body | | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0031595 | | nuclear proteasome complex | | A proteasome found in the nucleus of a cell. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0022624 | | proteasome accessory complex | | A protein complex, that caps one or both ends of the proteasome core complex and regulates entry into, or exit from, the proteasome core complex. |
| | GO:0000502 | | proteasome complex | | A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core. |
| | GO:0008540 | | proteasome regulatory particle, base subcomplex | | The subcomplex of the proteasome regulatory particle that directly associates with the proteasome core complex. |
|
Description
